Circulating microbiome in patients with portal hypertension

Standard

Circulating microbiome in patients with portal hypertension. / Gedgaudas, Rolandas; Bajaj, Jasmohan S; Skieceviciene, Jurgita; Varkalaite, Greta; Jurkeviciute, Gabija; Gelman, Sigita; Valantiene, Irena; Zykus, Romanas; Pranculis, Andrius; Bang, Corinna; Franke, Andre; Schramm, Christoph; Kupcinskas, Juozas.

In: GUT MICROBES, Vol. 14, No. 1, 2029674, 08.02.2022.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Gedgaudas, R, Bajaj, JS, Skieceviciene, J, Varkalaite, G, Jurkeviciute, G, Gelman, S, Valantiene, I, Zykus, R, Pranculis, A, Bang, C, Franke, A, Schramm, C & Kupcinskas, J 2022, 'Circulating microbiome in patients with portal hypertension', GUT MICROBES, vol. 14, no. 1, 2029674. https://doi.org/10.1080/19490976.2022.2029674

APA

Gedgaudas, R., Bajaj, J. S., Skieceviciene, J., Varkalaite, G., Jurkeviciute, G., Gelman, S., Valantiene, I., Zykus, R., Pranculis, A., Bang, C., Franke, A., Schramm, C., & Kupcinskas, J. (2022). Circulating microbiome in patients with portal hypertension. GUT MICROBES, 14(1), [2029674]. https://doi.org/10.1080/19490976.2022.2029674

Vancouver

Gedgaudas R, Bajaj JS, Skieceviciene J, Varkalaite G, Jurkeviciute G, Gelman S et al. Circulating microbiome in patients with portal hypertension. GUT MICROBES. 2022 Feb 8;14(1). 2029674. https://doi.org/10.1080/19490976.2022.2029674

Bibtex

@article{94e5073917274696a6bbf5b7a486b6a2,
title = "Circulating microbiome in patients with portal hypertension",
abstract = "Portal hypertension (PH) in liver cirrhosis leads to increased gut permeability and the translocation of bacteria across the gut-liver axis. Microbial DNA has recently been detected in different blood compartments; however, this phenomenon has not been thoroughly analyzed in PH. This study aimed to explore circulating bacterial DNA signatures, inflammatory cytokines, and gut permeability markers in different blood compartments (peripheral and hepatic veins) of patients with cirrhosis and PH. The 16S rRNA blood microbiome profiles were determined in 58 patients with liver cirrhosis and 46 control patients. Taxonomic differences were analyzed in relation to PH, liver function, inflammatory cytokines, and gut permeability markers. Circulating plasma microbiome profiles in patients with cirrhosis were distinct from those of the controls and were characterized by enrichment of Comamonas, Cnuella, Dialister, Escherichia/Shigella, and Prevotella and the depletion of Bradyrhizobium, Curvibacter, Diaphorobacter, Pseudarcicella, and Pseudomonas. Comparison of peripheral and hepatic vein blood compartments of patients with cirrhosis did not reveal differentially abundant taxa. Enrichment of the genera Bacteroides, Escherichia/Shigella, and Prevotella was associated with severe PH (SPH) in both blood compartments; however, circulating microbiome profiles could not predict PH severity. Escherichia/Shigella and Prevotella abundance was correlated with IL-8 levels in the hepatic vein. In conclusion, we demonstrated a distinct circulating blood microbiome profile in patients with cirrhosis, showing that specific bacterial genera in blood are marginally associated with SPH, Model for End-Stage Liver Disease score, and inflammation biomarkers; however, circulating microbial composition failed to predict PH severity.",
author = "Rolandas Gedgaudas and Bajaj, {Jasmohan S} and Jurgita Skieceviciene and Greta Varkalaite and Gabija Jurkeviciute and Sigita Gelman and Irena Valantiene and Romanas Zykus and Andrius Pranculis and Corinna Bang and Andre Franke and Christoph Schramm and Juozas Kupcinskas",
year = "2022",
month = feb,
day = "8",
doi = "10.1080/19490976.2022.2029674",
language = "English",
volume = "14",
journal = "GUT MICROBES",
issn = "1949-0976",
publisher = "LANDES BIOSCIENCE",
number = "1",

}

RIS

TY - JOUR

T1 - Circulating microbiome in patients with portal hypertension

AU - Gedgaudas, Rolandas

AU - Bajaj, Jasmohan S

AU - Skieceviciene, Jurgita

AU - Varkalaite, Greta

AU - Jurkeviciute, Gabija

AU - Gelman, Sigita

AU - Valantiene, Irena

AU - Zykus, Romanas

AU - Pranculis, Andrius

AU - Bang, Corinna

AU - Franke, Andre

AU - Schramm, Christoph

AU - Kupcinskas, Juozas

PY - 2022/2/8

Y1 - 2022/2/8

N2 - Portal hypertension (PH) in liver cirrhosis leads to increased gut permeability and the translocation of bacteria across the gut-liver axis. Microbial DNA has recently been detected in different blood compartments; however, this phenomenon has not been thoroughly analyzed in PH. This study aimed to explore circulating bacterial DNA signatures, inflammatory cytokines, and gut permeability markers in different blood compartments (peripheral and hepatic veins) of patients with cirrhosis and PH. The 16S rRNA blood microbiome profiles were determined in 58 patients with liver cirrhosis and 46 control patients. Taxonomic differences were analyzed in relation to PH, liver function, inflammatory cytokines, and gut permeability markers. Circulating plasma microbiome profiles in patients with cirrhosis were distinct from those of the controls and were characterized by enrichment of Comamonas, Cnuella, Dialister, Escherichia/Shigella, and Prevotella and the depletion of Bradyrhizobium, Curvibacter, Diaphorobacter, Pseudarcicella, and Pseudomonas. Comparison of peripheral and hepatic vein blood compartments of patients with cirrhosis did not reveal differentially abundant taxa. Enrichment of the genera Bacteroides, Escherichia/Shigella, and Prevotella was associated with severe PH (SPH) in both blood compartments; however, circulating microbiome profiles could not predict PH severity. Escherichia/Shigella and Prevotella abundance was correlated with IL-8 levels in the hepatic vein. In conclusion, we demonstrated a distinct circulating blood microbiome profile in patients with cirrhosis, showing that specific bacterial genera in blood are marginally associated with SPH, Model for End-Stage Liver Disease score, and inflammation biomarkers; however, circulating microbial composition failed to predict PH severity.

AB - Portal hypertension (PH) in liver cirrhosis leads to increased gut permeability and the translocation of bacteria across the gut-liver axis. Microbial DNA has recently been detected in different blood compartments; however, this phenomenon has not been thoroughly analyzed in PH. This study aimed to explore circulating bacterial DNA signatures, inflammatory cytokines, and gut permeability markers in different blood compartments (peripheral and hepatic veins) of patients with cirrhosis and PH. The 16S rRNA blood microbiome profiles were determined in 58 patients with liver cirrhosis and 46 control patients. Taxonomic differences were analyzed in relation to PH, liver function, inflammatory cytokines, and gut permeability markers. Circulating plasma microbiome profiles in patients with cirrhosis were distinct from those of the controls and were characterized by enrichment of Comamonas, Cnuella, Dialister, Escherichia/Shigella, and Prevotella and the depletion of Bradyrhizobium, Curvibacter, Diaphorobacter, Pseudarcicella, and Pseudomonas. Comparison of peripheral and hepatic vein blood compartments of patients with cirrhosis did not reveal differentially abundant taxa. Enrichment of the genera Bacteroides, Escherichia/Shigella, and Prevotella was associated with severe PH (SPH) in both blood compartments; however, circulating microbiome profiles could not predict PH severity. Escherichia/Shigella and Prevotella abundance was correlated with IL-8 levels in the hepatic vein. In conclusion, we demonstrated a distinct circulating blood microbiome profile in patients with cirrhosis, showing that specific bacterial genera in blood are marginally associated with SPH, Model for End-Stage Liver Disease score, and inflammation biomarkers; however, circulating microbial composition failed to predict PH severity.

U2 - 10.1080/19490976.2022.2029674

DO - 10.1080/19490976.2022.2029674

M3 - SCORING: Journal article

C2 - 35130114

VL - 14

JO - GUT MICROBES

JF - GUT MICROBES

SN - 1949-0976

IS - 1

M1 - 2029674

ER -